Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEMCAP-1
NCT06205342Phase 1Recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of mesenchymal stem cells in chronic pancreatitis (CP) (2 cohorts), sponsored by Medical University of South Carolina. Primary endpoint: Change in Izbicki pain score at 6 months. Started Jul 2024; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT06205342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205342.